- Latest news▼
-
18:00, April 18 Daily Mail: Elderly woman in China gets infected with brain-eating amoeba
-
14:19, April 18 Obesity: exercising before breakfast helps you lose weight faster
-
10:42, April 18 The Conversation: childhood trauma can cause pathological hoarding
-
08:37, April 18 Daily Mail: Satiating food reduces cravings for sweets, nutritionist says
-
18:22, April 17 First Armenian-German Conference entitled “Heart Failure Spring School”
-
08:38, April 17 Why do kids usually recover from COVID-19 more easily than adults?
-
14:37, April 16 Daily Mail: intermittent fasting is not suitable for children and women before their periods
-
16:41, April 15 Cell: in carriers of defective BRCA2 gene, sugar consumption increases cancer risk
-
15:04, April 15 305 cases of measles recorded in Armenia so far in 2024
-
14:38, April 15 Food and Environmental Virology: tea contributes to effective coronavirus control
-
12:41, April 15 Daily Mail: vitamin A, B3 and E supplements can be dangerous
-
10:56, April 15 Diabetes Care: evening physical activity is good for the heart
-
08:27, April 15 Women are more susceptible to blood loss and death during bypass surgery than men, researchers say
-
18:42, April 13 WHO: Nigeria pioneers revolutionary meningitis vaccine
-
16:43, April 13 One-third of women experience menstruation-related migraines, most often during premenopause - study
All materials
Glaxo recalls popular form of flu vaccine due to potency problem
GlaxoSmithKline is recalling a popular four-in-one flu vaccine distributed throughout the U.S. because its effectiveness can decline over time.
The company alerted customers Tuesday that the vaccine can lose potency and fail to adequately protect against some flu strains. The Flulaval Quadrivalent Thimerosal-free vaccine in prefilled syringes is designed to protect against four strains of influenza virus. But Glaxo said it "cannot rule out potential suboptimal protection" in people who received the vaccine in early January or later.
The recall affects about 1.7 million doses, but a company spokeswoman says it's unclear how many remain on the market. More than 99 percent of the vaccines were distributed in 2014, before the product began losing potency, according to GlaxoSmithKline's Anna Padula.
Health authorities generally recommend getting vaccinated in the fall.
Follow NEWS.am Medicine on Facebook and Twitter
- Video
- Event calendar
- Archive
- Most read
month
week
day
- Pediatrics: Hypoglossal nerve stimulation implant helps with sleep apnea 1344
- Health minister: Simulation educational center will be created, assisted reproductive technology capacity will increase in Armenia 1303
- WHO: Nigeria pioneers revolutionary meningitis vaccine 1154
- One-third of women experience menstruation-related migraines, most often during premenopause - study 1123
- Women are more susceptible to blood loss and death during bypass surgery than men, researchers say 835
- Food and Environmental Virology: tea contributes to effective coronavirus control 819
- Daily Mail: vitamin A, B3 and E supplements can be dangerous 817
- Cell: in carriers of defective BRCA2 gene, sugar consumption increases cancer risk 783
- 305 cases of measles recorded in Armenia so far in 2024 780
- Diabetes Care: evening physical activity is good for the heart 769
- Daily Mail: intermittent fasting is not suitable for children and women before their periods 596
- First Armenian-German Conference entitled “Heart Failure Spring School” 383
- Why do kids usually recover from COVID-19 more easily than adults? 202
- The Conversation: childhood trauma can cause pathological hoarding 163
- Daily Mail: Satiating food reduces cravings for sweets, nutritionist says 162
- Find us on Facebook
- Poll